BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10632061)

  • 1. Acid-sensitive polyethylene glycol conjugates of doxorubicin: preparation, in vitro efficacy and intracellular distribution.
    Rodrigues PC; Beyer U; Schumacher P; Roth T; Fiebig HH; Unger C; Messori L; Orioli P; Paper DH; Mülhaupt R; Kratz F
    Bioorg Med Chem; 1999 Nov; 7(11):2517-24. PubMed ID: 10632061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the acid-sensitivity of polyethylene glycol daunorubicin conjugates with their in vitro antiproliferative activity.
    Rodrigues PC; Roth T; Fiebig HH; Unger C; Mülhaupt R; Kratz F
    Bioorg Med Chem; 2006 Jun; 14(12):4110-7. PubMed ID: 16546396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin conjugates of doxorubicin: synthesis, characterization, cellular uptake, and in vitro efficacy.
    Kratz F; Beyer U; Roth T; Tarasova N; Collery P; Lechenault F; Cazabat A; Schumacher P; Unger C; Falken U
    J Pharm Sci; 1998 Mar; 87(3):338-46. PubMed ID: 9523988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
    Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
    Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.
    Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X
    Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
    Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
    Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.
    Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F
    Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
    Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, physiochemical characterization, and in vitro antitumor activity of the amide and pH cleavable hydrazone conjugates of γ-tocotrienol isomer of vitamin E with methoxy-poly(ethylene) glycol.
    Abu-Fayyad A; Nazzal S
    Int J Pharm; 2017 Aug; 529(1-2):75-86. PubMed ID: 28627454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles of pH-Responsive, PEG-Doxorubicin Conjugates: Interaction with an in Vitro Model of Lung Adenocarcinoma and Their Direct Formulation in Propellant-Based Portable Inhalers.
    Rao KSVK; Zhong Q; Bielski ER; da Rocha SRP
    Mol Pharm; 2017 Nov; 14(11):3866-3878. PubMed ID: 28972765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxime linkage: a robust tool for the design of pH-sensitive polymeric drug carriers.
    Jin Y; Song L; Su Y; Zhu L; Pang Y; Qiu F; Tong G; Yan D; Zhu B; Zhu X
    Biomacromolecules; 2011 Oct; 12(10):3460-8. PubMed ID: 21863891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Polymer Size on Uptake and Cytotoxicity of Doxorubicin-Loaded DNA-PEG Conjugates.
    Purdie L; Alexander C; Spain SG; Magnusson JP
    Bioconjug Chem; 2016 May; 27(5):1244-52. PubMed ID: 27074730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
    Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
    Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel peptide conjugates for tumor-specific chemotherapy.
    Langer M; Kratz F; Rothen-Rutishauser B; Wunderli-Allenspach H; Beck-Sickinger AG
    J Med Chem; 2001 Apr; 44(9):1341-8. PubMed ID: 11311056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization and in vitro efficacy of albumin conjugates of doxorubicin.
    Kratz F; Beyer U; Collery P; Lechenault F; Cazabat A; Schumacher P; Falken U; Unger C
    Biol Pharm Bull; 1998 Jan; 21(1):56-61. PubMed ID: 9477169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular uptake, intracellular trafficking, and antitumor efficacy of doxorubicin-loaded reduction-sensitive micelles.
    Cui C; Xue YN; Wu M; Zhang Y; Yu P; Liu L; Zhuo RX; Huang SW
    Biomaterials; 2013 May; 34(15):3858-69. PubMed ID: 23452389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Responsive Reversible PEGylation Improves Performance of Antineoplastic Agent.
    Sun D; Ding J; Xiao C; Chen J; Zhuang X; Chen X
    Adv Healthc Mater; 2015 Apr; 4(6):844-55. PubMed ID: 25645303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.